Skip to main content
. 2010 Oct 1;10(7):703–711. doi: 10.4161/cbt.10.7.12904

Figure 5.

Figure 5

The light microscope images of the invaded E0771 cells on the outside of Matrigel inserts (A: Control; B: SU11248). VEGF receptor inhibitor, SU11248 at 10 µmol/L, significantly inhibited the migration of mouse breast cancer cells (E0771) in Matrigel by 47%, compared to the control group (61 ± 3 vs. 32 ± 2 invaded cell numbers/mm2; p < 0.01; n = 8).